Story

Pearson Stock Slides After JPMorgan Ends Six-Year Bullish Stance with Downgrade

ENTHMSVIIDZHZH-TWJAKOHI
Jul 14, 20262 min read
Pearson Stock Slides After JPMorgan Ends Six-Year Bullish Stance with Downgrade

Summary

Shares in the education company fell after JPMorgan downgraded the stock to Neutral from Overweight, citing a valuation that has outpaced fundamentals after a run-up to a 52-week high.

Text size
Background

Shares of Pearson (LSE:PSON) fell sharply on Tuesday after a high-profile analyst at JPMorgan downgraded the stock, ending a long-standing bullish view and raising concerns about the company's valuation after a recent rally.

JPMorgan Reverses Course

JPMorgan analyst Daniel Kerven downgraded Pearson to Neutral from a long-held Overweight rating, a bullish stance the bank had maintained for the past six years. The price target was also trimmed slightly to £14.20 from £14.30. The downgrade's significance is amplified as Pearson had been one of JPMorgan's key stock picks for 2026.

The analyst's rationale is that the stock's strong performance has pushed its valuation ahead of its underlying fundamentals. Kerven argued that even assuming Pearson meets its own guidance for mid-single-digit revenue growth, the current share price leaves only modest potential upside for investors. JPMorgan also noted it sees more compelling opportunities elsewhere in the information services sector.

Market Reaction and Context

The downgrade triggered a notable sell-off, with Pearson's stock falling 3.3% to trade at 1,275p. The move is a sharp reversal for the shares, which had just reached a 52-week high, making the stock vulnerable to profit-taking on negative news.

Sample IUX Markets – In-articleAd

A broader risk-off sentiment in the market contributed to the pressure. U.S. equity indices were also trading lower, adding to the headwinds for stocks like Pearson that are trading near peak valuations. The removal of a key institutional supporter like JPMorgan creates a significant sentiment shift for the stock.

Fundamentals Seen as Priced In

While Pearson's operational backdrop remains solid, the market appears to believe these strengths are now fully reflected in the price. The company recently reported 4% revenue growth for the first quarter of 2026, reaffirmed its full-year guidance, and is executing a £350 million share buyback program.

However, after a significant year-to-date rally, the JPMorgan downgrade suggests that there are limited near-term catalysts to justify further multiple expansion. The consensus among analysts covering the stock now sits at a more cautious "Hold."

Read next

More on Stocks
Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Stocks

Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Sep 20, 2026

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has resubmitted its application for a main board listing on the Hong Kong Stock Exchange, aiming to secure a dual listing to access international capital. The company specializes in drugs for central nervous system and cardiovascular diseases.

Back to latest news

LATEST